Access Statistics for Karl Claxton

Author contact details at EconPapers.

Working Paper File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
A Pilot Study of Value of Information Analysis to Support Research Recommendations for the National Institute for Health and Clinical Excellence 0 0 1 109 0 1 5 605
Accounting for timing when assessing health-related policies 0 0 0 11 0 0 2 38
An Economic Approach to Clinical Trial Design and Research Priority Setting 0 0 0 0 0 1 4 880
Appropriate Perspectives for Health Care Decisions 0 0 4 673 1 2 14 2,037
Assessing health opportunity costs for the Indian health care systems 0 0 2 31 0 2 23 163
Assessing the impact of health care expenditures on mortality using cross-country data 1 1 1 85 1 1 5 110
Bayesian Value-of-Information Analysis: An Application to a Policy Model of Alzheimer's Disease 0 0 0 600 0 0 2 2,319
Budget allocation and the revealed social rate of time preference for health 0 0 0 85 1 2 6 358
Budgetary policies and available actions: a generalisation of decision rules for allocation and research decisions 0 1 1 46 0 3 6 183
Cost per DALY averted thresholds for low- and middle-income countries: evidence from cross country data 3 5 11 106 19 28 50 328
Country-level cost-effectiveness thresholds: initial estimates and the need for further research 0 0 0 31 3 3 8 149
Coverage with evidence development, only in research, risk sharing or patient access scheme? A framework for coverage decisions 0 1 1 29 0 2 10 154
Defining and characterising structural uncertainty in decision analytic models 0 0 0 187 0 1 9 896
Dimensions of design space: a decision-theoretic approach to optimal research design 0 0 0 53 0 0 4 456
Effects of Fundholding on the Prescribing and Referral Behavior of General Practitioners 0 0 0 0 0 0 1 119
Estimating the marginal productivity of the English National Health Service from 2003/04 to 2012/13 1 1 2 57 3 5 11 130
Expected health benefits of additional evidence: Principles, methods and applications 0 0 0 22 0 1 4 102
Improving the efficiency and relevance of health technology assessent: the role of iterative decision analytic modelling 0 0 0 89 0 0 2 368
Is an ounce of prevention worth a pound of cure? Estimates of the impact of English public health grant on mortality and morbidity 0 0 1 66 0 2 26 320
Mark versus Luke? Appropriate Methods for the Evaluation of Public Health Interventions 0 0 3 370 0 2 11 1,067
Methods for the estimation of the NICE cost effectiveness threshold 0 0 9 188 1 2 26 763
Modelling the behaviour of general practitioners: a theoretical foundation for studies of fundholding 0 0 0 31 0 1 3 148
Setting research priorities in Global Health:Appraising the value of evidence generation activities to support decision-making in health care 0 0 2 22 0 2 6 45
Supporting the development of an essential health package: principles and initial assessment for Malawi 0 0 1 67 2 11 26 316
The NICE Cost-Effectiveness Threshold: What it is and What that Means 0 0 2 85 0 1 7 283
The Role of Decision Analysis in Structuring the Economic Evaluation of Sequential Clinical Decision Problems 0 0 0 0 1 1 2 212
The value of implementation and the value of information: combined and uneven development 0 0 0 34 1 2 9 182
Uncertainty, evidence and irrecoverable costs: Informing approval, pricing and research decisions for health technologies 0 0 0 31 0 2 6 200
Using cost-effectiveness thresholds to determine value for money in low- and middle-income country healthcare systems: Are current international norms fit for purpose? 0 0 3 160 3 3 15 493
Value-based pricing for pharmaceuticals: Its role, specification and prospects in a newly devolved NHS 0 0 5 707 3 4 15 2,221
Total Working Papers 5 9 49 3,975 39 85 318 15,645


Journal Article File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
A dynamic programming approach to the efficient design of clinical trials 0 0 1 51 0 1 8 133
Accounting for Timing when Assessing Health-Related Policies 0 1 1 5 0 1 3 30
Bayesian approaches to the value of information: implications for the regulation of new pharmaceuticals 2 2 2 6 2 3 5 143
Budget allocation and the revealed social rate of time preference for health 0 0 0 3 0 1 2 57
Budgetary policies and available actions: A generalisation of decision rules for allocation and research decisions 0 0 0 23 0 2 6 95
CAUSES FOR CONCERN: IS NICE FAILING TO UPHOLD ITS RESPONSIBILITIES TO ALL NHS PATIENTS? 0 0 0 7 0 1 2 41
Comment: Positive tails and normative dogs 0 0 0 1 0 0 1 12
Dangerous omissions: the consequences of ignoring decision uncertainty 0 0 1 7 0 0 1 33
Discounting and cost‐effectiveness in NICE – stepping back to sort out a confusion 0 0 0 88 0 0 1 302
Discounting and decision making in the economic evaluation of health‐care technologies 0 0 5 72 1 1 11 291
Discounting in Economic Evaluations 0 0 4 5 0 1 11 59
Evidence synthesis, parameter correlation and probabilistic sensitivity analysis 0 0 0 69 0 0 0 267
How to design the cost‐effectiveness appraisal process of new healthcare technologies to maximise population health: A conceptual framework 0 0 0 5 0 0 1 22
In recognition of Anthony J. Culyer 0 0 2 26 0 0 4 88
Methods for assessing the cost-effectiveness of public health interventions: Key challenges and recommendations 0 0 3 84 0 1 7 283
OFT, VBP: QED? 0 0 0 42 0 1 3 178
Probabilistic sensitivity analysis for NICE technology assessment: not an optional extra 0 0 0 159 1 1 6 610
Real Economics Needs to Reflect Real Decisions 0 0 0 23 0 0 0 86
Redefining the analytical approach to pharmacoeconomics 0 0 0 2 0 1 2 67
Representing uncertainty: the role of cost‐effectiveness acceptability curves 0 0 0 175 0 0 5 510
Selecting treatments: a decision theoretic approach 0 0 0 10 0 0 1 55
Sins of omission and obfuscation: IQWIG's guidelines on economic evaluation methods 0 0 0 27 0 0 3 108
Social value and individual choice: The value of a choice‐based decision‐making process in a collectively funded health system 0 0 0 0 0 0 0 8
The Value of Further Research: The Added Value of Individual-Participant Level Data 0 0 0 3 0 0 2 20
The impact of NHS expenditure on health outcomes in England: Alternative approaches to identification in all‐cause and disease specific models of mortality 0 1 2 6 0 1 4 20
The irrelevance of inference: a decision-making approach to the stochastic evaluation of health care technologies 1 1 1 203 4 6 10 516
Uncertainty and value of information when allocating resources within and between healthcare programmes 0 0 1 38 0 1 4 97
Unrelated Future Costs and Unrelated Future Benefits: Reflections on NICE Guide to the Methods of Technology Appraisal 0 0 0 1 0 1 2 27
When Does NICE Recommend the Use of Health Technologies Within a Programme of Evidence Development? 0 0 0 0 0 0 1 16
Whither trial‐based economic evaluation for health care decision making? 0 0 0 64 0 0 2 267
Total Journal Articles 3 5 23 1,205 8 24 108 4,441


Book File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Decision Modelling for Health Economic Evaluation 0 0 0 0 5 17 98 4,008
Methods for the Economic Evaluation of Health Care Programmes 0 0 0 0 12 31 101 567
Total Books 0 0 0 0 17 48 199 4,575
1 registered items for which data could not be found


Chapter File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Decision-making with Uncertainty: The Value of Information 0 0 0 36 0 1 7 125
Decision-making with Uncertainty: The Value of Information 0 0 1 14 0 0 3 41
Total Chapters 0 0 1 50 0 1 10 166


Statistics updated 2025-10-06